$15.3 M

ACHV Mkt cap, 29-May-2020
Achieve Life Sciences Net income (Q1, 2020)-3.3 M
Achieve Life Sciences Cash, 31-Mar-202012.2 M
Achieve Life Sciences EV3.5 M

Achieve Life Sciences Income Statement

Annual

USDFY, 2011FY, 2012FY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018FY, 2019

Revenue

R&D expense

21.6m39.9m55.3m46.2m25.1m14.8m3.1m5.9m9.7m

General and administrative expense

6.2m7.8m9.9m10.6m11.8m8.9m3.5m6.9m6.9m

Operating expense total

27.8m49.4m65.2m56.8m36.9m23.7m6.6m12.8m16.5m

Depreciation and amortization

200.0k200.0k200.0k

Interest expense

7.6m4.9m3.5m3.2m2.0m1.1m7.0m126.0k

Interest income

220.0k292.0k150.0k35.0k119.0k203.0k21.0k171.0k170.0k

Pre tax profit

(14.7m)(21.1m)(13.6m)(12.7m)(16.4m)

Income tax expense

(3.1m)

Net Income

(14.7m)(21.1m)(31.8m)(26.2m)(16.8m)(20.1m)(10.6m)(12.7m)(16.4m)

Achieve Life Sciences Balance Sheet

Quarterly

USDQ2, 2011Q3, 2011Q1, 2012Q2, 2012Q3, 2012Q1, 2013Q2, 2013Q3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019Q3, 2019Q1, 2020

Cash

20.9m15.7m56.9m13.8m11.4m18.6m18.7m13.0m28.6m40.6m49.0m25.3m48.0m42.5m18.9m10.6m11.8m15.7m13.9m8.0m4.2m15.3m11.8m7.3m10.4m7.4m12.2m

Accounts Receivable

1.5m987.0k774.0k956.0k1.1m5.2m6.4m9.9m8.6m5.0m4.8m1.6m149.0k13.0k237.0k241.0k70.0k7.0k124.0k25.0k

Prepaid Expenses

1.4m3.4m2.1m6.0m9.3m3.4m3.5m2.7m1.8m2.3m2.5m3.0m2.0m1.6m1.6m1.3m1.6m765.0k307.0k535.0k352.0k168.0k349.0k866.0k356.0k264.0k746.0k

Current Assets

78.8m74.0m114.6m104.9m95.8m73.5m67.3m59.7m48.1m47.9m61.3m45.5m62.7m67.6m48.0m41.4m34.3m17.5m14.5m8.6m4.7m15.6m13.5m10.5m10.8m7.6m12.9m

PP&E

207.0k198.0k161.0k226.0k223.0k437.0k496.0k443.0k349.0k354.0k312.0k416.0k406.0k380.0k546.0k534.0k493.0k166.0k129.0k94.0k18.0k42.0k32.0k80.0k71.0k64.0k52.0k

Goodwill

1.0m1.0m1.0m1.0m1.0m1.0m1.0m1.0m

Total Assets

79.5m74.7m115.2m108.0m97.2m75.4m69.3m61.6m49.8m49.7m62.7m46.4m63.4m68.2m48.8m42.2m35.1m17.9m14.9m13.0m8.5m19.2m17.1m14.5m14.8m11.5m16.6m

Accounts Payable

1.6m1.5m2.9m2.9m5.7m7.9m130.0k39.0k923.0k1.3m1.6m988.0k302.0k1.8m592.0k559.0k1.0m359.0k233.0k495.0k420.0k251.0k458.0k694.0k707.0k574.0k184.0k

Short-term debt

1.4m1.4m1.4m1.4m1.5m1.1m1.1m1.1m1.1m1.1m1.1m52.0k54.0k53.0k51.0k57.0k57.0k55.0k46.0k31.0k11.0k11.0k196.0k

Current Liabilities

27.9m19.1m31.0m27.4m21.7m11.0m12.7m14.4m16.9m20.2m20.9m16.2m35.0m29.3m14.5m13.9m10.6m2.0m1.8m2.3m2.3m2.8m3.0m4.0m3.0m3.1m1.5m

Long-term debt

6.6m6.5m6.1m5.9m5.7m4.1m3.9m3.7m3.3m3.1m2.9m128.0k130.0k117.0k92.0k84.0k67.0k32.0k22.0k16.0k18.0k15.0k313.0k263.0k212.0k118.0k

Total Debt

8.0m7.9m7.6m7.4m7.2m5.2m5.0m4.8m4.4m4.2m4.0m180.0k184.0k170.0k143.0k141.0k124.0k87.0k68.0k47.0k29.0k26.0k313.0k263.0k212.0k314.0k

Total Liabilities

44.3m34.7m37.1m33.3m27.4m15.1m16.6m18.1m20.2m23.3m23.8m16.4m35.2m29.5m14.6m13.9m10.7m2.0m1.8m2.3m2.3m2.8m3.0m4.3m3.3m3.4m1.7m

Common Stock

10.0k10.0k15.0k14.0k15.0k15.0k15.0k15.0k15.0k15.0k21.0k22.0k24.0k30.0k30.0k29.0k30.0k30.0k30.0k11.0k13.0k15.0k16.0k18.0k19.0k19.0k43.0k

Additional Paid-in Capital

108.2m108.7m163.1m163.9m164.8m166.2m167.0m167.9m169.3m173.1m190.5m191.9m196.1m211.2m212.1m213.0m212.8m213.5m213.7m19.6m21.8m34.9m35.9m41.5m50.3m50.6m64.0m

Retained Earnings

(75.6m)(71.2m)(87.6m)(91.8m)(97.7m)(108.5m)(117.0m)(127.0m)(142.3m)(149.3m)(154.3m)(164.5m)(170.5m)(175.1m)(180.5m)(187.4m)(191.1m)(200.2m)(203.2m)(8.9m)(15.7m)(18.5m)(21.7m)(31.3m)(38.8m)(42.5m)(49.0m)

Total Equity

35.2m40.0m78.1m74.7m69.8m60.3m52.7m43.5m29.6m26.5m38.9m30.0m28.2m38.8m34.2m28.2m24.4m15.9m13.1m10.7m6.1m16.4m14.2m10.2m11.5m8.1m15.0m

Financial Leverage

2.3 x1.9 x1.5 x1.4 x1.4 x1.3 x1.3 x1.4 x1.7 x1.9 x1.6 x1.5 x2.2 x1.8 x1.4 x1.5 x1.4 x1.1 x1.1 x1.2 x1.4 x1.2 x1.2 x1.4 x1.3 x1.4 x1.1 x

Achieve Life Sciences Cash Flow

Quarterly

USDQ2, 2011Q3, 2011Q1, 2012Q2, 2012Q3, 2012Q1, 2013Q2, 2013Q3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019Q3, 2019Q1, 2020

Net Income

(9.6m)(5.1m)(6.9m)11.1m17.0m(6.7m)(15.1m)(25.2m)(8.6m)(15.7m)(20.6m)(4.5m)(10.5m)(15.1m)(3.7m)(10.6m)(14.3m)(3.3m)(6.3m)(6.8m)(3.0m)(5.8m)(9.0m)(5.9m)(9.5m)(13.2m)(3.3m)

Depreciation and Amortization

37.0k56.0k19.0k43.0k71.0k44.0k100.0k162.0k55.0k110.0k165.0k46.0k116.0k178.0k56.0k103.0k148.0k93.0k130.0k191.0k86.0k154.0k220.0k65.0k130.0k192.0k61.0k

Accounts Receivable

(274.0k)237.0k38.0k(144.0k)(326.0k)(4.4m)(5.7m)(9.2m)47.0k3.7m3.8m4.1m5.5m5.7m(219.0k)(293.0k)(144.0k)241.0k237.0k(164.0k)(21.0k)(16.0k)8.0k

Accounts Payable

750.0k572.0k(340.0k)(334.0k)2.5m875.0k(1.2m)(1.3m)784.0k1.2m1.4m916.0k230.0k1.7m(751.0k)(784.0k)(300.0k)(1.8m)(1.9m)400.0k207.0k38.0k245.0k550.0k563.0k430.0k(675.0k)

Cash From Operating Activities

(9.6m)(15.8m)(7.4m)(21.1m)(34.0m)(10.7m)(18.2m)(28.4m)(1.7m)(4.6m)(10.4m)(6.4m)10.2m1.6m(9.1m)(15.4m)(22.7m)(9.0m)(11.5m)(5.5m)(2.2m)(4.1m)(7.1m)(4.9m)(8.7m)(11.8m)(4.5m)

Purchases of PP&E

(68.0k)(76.0k)(89.0k)(114.0k)(110.0k)(225.0k)(234.0k)(7.0k)(67.0k)(80.0k)(205.0k)(265.0k)(301.0k)(35.0k)(39.0k)(1.0k)(1.0k)(36.0k)(36.0k)(54.0k)(52.0k)(52.0k)(2.0k)

Cash From Investing Activities

7.0m7.9m(18.1m)(47.5m)(37.4m)11.2m18.8m23.2m15.7m24.6m19.5m3.9m6.7m(4.6m)(6.3m)(8.3m)194.0k9.5m10.2m12.4m10.0k(26.0k)(1.4m)2.7m5.0m5.0m(2.0k)

Cash From Financing Activities

91.0k213.0k53.8m53.9m54.2m10.0k10.0k10.0k30.0k6.1m25.2m(52.0k)3.2m17.6m(19.0k)(22.0k)1.1m1.1m13.9m14.7m4.6m4.6m(47.0k)

Net Change in Cash

2.7m(7.8m)28.3m(14.7m)(17.2m)553.0k674.0k(5.1m)14.0m26.0m34.4m(2.6m)20.1m14.6m(15.4m)(23.7m)(22.5m)457.0k(1.3m)8.0m(1.1m)9.8m6.2m(2.2m)931.0k(2.1m)(4.5m)

Achieve Life Sciences Ratios

USDY, 2020

EV/CFO

-0.8 x

Financial Leverage

1.1 x